Due to the increasing prevalence of COVID-19, the All Wales Medical Genomics Laboratory, like the whole NHS, is currently experiencing staff shortages.
Due to the increasing prevalence of covid-19, the All Wales Medical Genomics Laboratory, like the whole NHS, is currently experiencing staff shortages.
Welsh government pledge £15.3m to fund new state of the art genomics innovation park
The All Wales Medical Genomics Service (AWMGS) are delighted to announce the business case submitted to Welsh Government seeking capital funding to secure Cardiff Edge has been ratified and officially approved by the Health Minister for Wales, Eluned Morgan.
Launch of the CYmru Service for Genomic Oncology DIagnoses (CYSGODI)
The All Wales Medical Genomics Service (AWMGS) is thrilled to announce the launch of the CYmru Service for Genomic Oncology DIagnoses, otherwise abbreviated as CYSGODI.
DPYD screening now offered to cancer patients in Wales
The All Wales Medical Genomics Service is thrilled to announce the availability of DPYD screening for cancer patients in Wales who are being treated with certain types of chemotherapy.
Change in JAK2 Exon 12 and MPL Testing Provision by AWMGS
Change in JAK2 Exon 12 and MPL Testing Provision by AWMGS
From 20/04/2020 the All Wales Genomic Laboratory will be providing JAK2 exon 12 and MPL testing service using the Illumina Myeloid panel. These tests will no longer be sent to Bristol for testing.
Guidance for genetic testing provision within the Constitutional section of the All Wales Medical Genomics Service (AWMGS) in response to COVID-19
In view of the current COVID-19 pandemic, there are changes to a number of the routine rare disease tests performed by the laboratory. Please note, urgent services are unaffected and all tests are available.
AWMGS wins prestigious award for NIPT contribution in Wales
The All Wales Medical Genomics Service (AWMGS) attended the 14th Annual MediWales Awards ceremony on December 4th at the National Museum of Wales, an opportunity for over '300 VIP guests to celebrate the achievements of the NHS, Life Sciences and Health Technology Communities'.
Navigating the world of Genetics and Genomics can be challenging to digest...
FutureLearn has compiled a suite of interactive e-learning courses, tailored appropriately for all audiences.
NGS Screening Service for Familial Hypercholesterolaemia (FH)
We are pleased to announce that our long awaited next generation sequencing (NGS) screening service for familial hypercholesterolaemia (FH) has ‘gone live' on Wednesday October 2nd.
The Head of Laboratory at the All Wales Medical Genomics Service would like to thank all the speakers and attendees for a successful Precision Medicine Cancer Diagnosis Networking Event.
